Nuclear medicine for the Future
Pierre and Marie Curie knew immediately when they discovered radioactivity how promising it would be for medical research. Bringing progress to the area of nuclear medicine, Orano Med, Orano’s medical subsidiary, has developed a new generation of targeted therapies against cancer using the unique properties of lead-212. Take a detailed look at a lesser-known use of nuclear energy.
Our articles about nuclear medicine
Nuclear medecine against cancer
Orano Med, the medical subsidiary of Orano, is combining biotechnology and nuclear science to develop a new generation of targeted therapies against cancer using the unique properties of Lead-212.
Discover
Fighting cancer: history and role of nuclear medicine
Discover how nuclear medicine techniques and the use of lead-212 are enabling Orano Med to develop new cancer therapies.
Discover
Since the beginning of the 20th century, with Pierre and Marie Curie leading the way, nuclear materials have been used to treat patients (radium) and improve diagnostics through medical imaging (X-rays). Today, nuclear medicine offers more and more accurate diagnostics using scintigraphy and tomography.
Orano’s expertise in transforming nuclear materials has progressed in recent years with the development of anticancer treatments and medical research using isotopes. This is the case for lead-212. Orano Med, Orano’s medical subsidiary, has developed a new and very promising process to extract and purify lead-212 for targeted alpha therapy, an innovative form of cancer radiotherapy that reduces the impact on healthy cells.